122
Participants
Start Date
August 1, 2019
Primary Completion Date
August 31, 2020
Study Completion Date
December 31, 2020
Pirfenidone
Treatment consist of 600 mg tablets of a prolonged-released formulation of Pirfenidone. Patients are instructed to take medication orally, every 12 h, after breakfast and dinner.
Standard of care
All participants will require to adhere to a standard of care including nutritional support, quarterly medical evaluation to review lab results and adjust medications, bi-annual Fibrotest, FibroScan and liver ultrasound, and annual upper-gastrointestinal endoscopy.
Liver Clinic 1, Mexico City
Grupo Mexicano para el Estudios de las Enfermedades Hepaticas
OTHER